1483 related articles for article (PubMed ID: 16430100)
21. Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry.
Ghoshal UC; Chourasia D; Tripathi S; Misra A; Singh K
Scand J Gastroenterol; 2008; 43(6):654-61. PubMed ID: 18569981
[TBL] [Abstract][Full Text] [Related]
22. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough.
Ours TM; Kavuru MS; Schilz RJ; Richter JE
Am J Gastroenterol; 1999 Nov; 94(11):3131-8. PubMed ID: 10566703
[TBL] [Abstract][Full Text] [Related]
23. Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies.
Sontag SJ; O'Connell S; Khandelwal S; Greenlee H; Schnell T; Nemchausky B; Chejfec G; Miller T; Seidel J; Sonnenberg A
Am J Gastroenterol; 2003 May; 98(5):987-99. PubMed ID: 12809818
[TBL] [Abstract][Full Text] [Related]
24. Extraesophageal GERD.
Frye JW; Vaezi MF
Gastroenterol Clin North Am; 2008 Dec; 37(4):845-58, ix. PubMed ID: 19028321
[TBL] [Abstract][Full Text] [Related]
25. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
Weigt J; Kandulski A; Büsch F; Malfertheiner P
Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
[TBL] [Abstract][Full Text] [Related]
26. [Prevalence of gastroesophageal reflux disease in patients with bronchial asthma].
Bocheńska-Marciniak M; Górski P
Pol Merkur Lekarski; 2004 Jun; 16(96):527-31. PubMed ID: 15510889
[TBL] [Abstract][Full Text] [Related]
27. [The laryngological complications of the Gastroesophageal Reflux Diseases].
Skrodzka D; Wereszczyńska-Siemiatkowska U; Południewska B; Kasprowicz JB
Przegl Lek; 2006; 63(9):752-5. PubMed ID: 17479863
[TBL] [Abstract][Full Text] [Related]
28. Combined pH-metry/impedance monitoring increases the diagnostic yield in patients with atypical gastroesophageal reflux symptoms.
Bajbouj M; Becker V; Neuber M; Schmid RM; Meining A
Digestion; 2007; 76(3-4):223-8. PubMed ID: 18174685
[TBL] [Abstract][Full Text] [Related]
29. [Effects of proton pump inhibitor on airway hyperresponsiveness in asthmatics with gastroesophageal reflux].
Sato A; Tanifuji Y; Kobayashi H; Inoue H
Arerugi; 2006 Jun; 55(6):641-6. PubMed ID: 16883100
[TBL] [Abstract][Full Text] [Related]
30. The potential role of gastroesophageal reflux in asthma.
Harding SM
Minerva Gastroenterol Dietol; 2001 Jun; 47(2):75-83. PubMed ID: 16493363
[TBL] [Abstract][Full Text] [Related]
31. Bronchial hyperreactivity in non-atopic children with asthma and reflux: effect of anti-reflux treatment.
Khoshoo V; Mohnot S; Haydel R; Saturno E; Edell D; Kobernick A
Pediatr Pulmonol; 2009 Nov; 44(11):1070-4. PubMed ID: 19830719
[TBL] [Abstract][Full Text] [Related]
32. [Chronic respiratory disease in patients with GERD].
Dobashi K
Nihon Rinsho; 2004 Aug; 62(8):1537-41. PubMed ID: 15344547
[TBL] [Abstract][Full Text] [Related]
33. [Findings of 24-hour esophageal pH monitoring in patients with respiratory and otorhinolaryngologic manifestations of gastroesophageal reflux disease].
Karoui S; Zouiten L; Matri S; Boubaker J; Filali A
Tunis Med; 2006 Mar; 84(3):165-9. PubMed ID: 16755957
[TBL] [Abstract][Full Text] [Related]
34. Role of GERD in chronic resistant sinusitis: a prospective, open label, pilot trial.
DiBaise JK; Olusola BF; Huerter JV; Quigley EM
Am J Gastroenterol; 2002 Apr; 97(4):843-50. PubMed ID: 12003417
[TBL] [Abstract][Full Text] [Related]
35. [Prevalence, diagnosis and treatment of extraesophageal manifestations of GERD].
Sugawa T; Fujiwara Y; Okuyama M; Tanigawa T; Shiba M; Tominaga K; Watanabe T; Oshitani N; Higuchi K; Arakawa T
Nihon Rinsho; 2007 May; 65(5):946-50. PubMed ID: 17511238
[TBL] [Abstract][Full Text] [Related]
36. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure.
Noar MD; Lotfi-Emran S
Gastrointest Endosc; 2007 Mar; 65(3):367-72. PubMed ID: 17321232
[TBL] [Abstract][Full Text] [Related]
37. Gastroesophageal reflux disease: extraesophageal manifestations and therapy.
DeVault KR
Semin Gastrointest Dis; 2001 Jan; 12(1):46-51. PubMed ID: 11215855
[TBL] [Abstract][Full Text] [Related]
38. Atypical presentations of gastroesophageal reflux disease.
Heidelbaugh JJ; Gill AS; Van Harrison R; Nostrant TT
Am Fam Physician; 2008 Aug; 78(4):483-8. PubMed ID: 18756656
[TBL] [Abstract][Full Text] [Related]
39. Use of an endoscopic suturing device (the "ESD") to treat patients with gastroesophageal reflux disease, after unsuccessful EndoCinch endoluminal gastroplication: another failure.
Schiefke I; Neumann S; Zabel-Langhennig A; Moessner J; Caca K
Endoscopy; 2005 Aug; 37(8):700-5. PubMed ID: 16032486
[TBL] [Abstract][Full Text] [Related]
40. [Sleep disorders in patients with gastroesophageal reflux disease: an open clinical and pH metric prospective study].
Karoui S; Chtara O; Bibani N; Kallel L; Zouiten L; Matri S; Serghini M; Boubaker J; Filali A
Tunis Med; 2010 Mar; 88(3):172-7. PubMed ID: 20415190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
